A Clinical Trial To Study The Effect Of 2 Therapies or Procedures In Participants Or Patients i.e. Intervention Of Enema Therapy and Purgative Therapy With The Drug Named Trivrutta Avleh For Reduction Of Signs and Symptoms Specifically In Hyperacidity Patients.

Comparative Study Of Pittaghna Asthapan Basti And Virechan With Trivrutta Leh In Amlapitta - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095406

Enrollment

100

Registered

2025-09-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients showing classical signs and symptoms of Amlapitta for more than one year will be selected for study. 2.Either Male or female patients fit for virechan and asthapan basti.

Exclusion criteria

Exclusion criteria: 1.Patients with complications like cardiac problems, fissure, bleeding piles, malignant conditions. 2.Pregnant women and Lactating mothers will be excluded. 3.Patients above 50yrs and below 18 yrs. 4.Contraindications of virechan and Niruh basti.

Design outcomes

Primary

Measure	Time frame
Reduction of Signs and Symptoms of Amla PittaTimepoint: Baseline, 15th day, 30th day	—

Secondary

Measure	Time frame
NIlTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Shruti Bagewadikar

Bharati Vidyapeeth College of Ayurved and Hospital

shubhangi.katkar@bharatividyapeeth.edu9850904374

Outcome results